BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.36% | 7,326.77% | 100.91% | -15.12% | -0.78% |
| Total Depreciation and Amortization | 19.70% | -5.58% | -81.06% | 138.26% | 195.13% |
| Total Amortization of Deferred Charges | -73.26% | 390.11% | -75.20% | 298.74% | 0.76% |
| Total Other Non-Cash Items | 9.43% | 45.75% | -62.81% | 119.26% | -4.71% |
| Change in Net Operating Assets | 1,768.48% | 106.86% | 50.35% | -220.46% | 215.04% |
| Cash from Operations | 52.71% | 497.97% | -60.50% | -40.75% | 297.06% |
| Capital Expenditure | -9.72% | 22.30% | 35.73% | 34.34% | -21.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.78% | 65.24% | 58.93% | -70,187.53% | 79.02% |
| Cash from Investing | 26.02% | 45.38% | 50.69% | -84.73% | -20.58% |
| Total Debt Issued | -100.00% | 76.90% | -85.42% | -- | -100.00% |
| Total Debt Repaid | 96.31% | 34.83% | 68.30% | -15,591.70% | 97.88% |
| Issuance of Common Stock | 142.99% | -47.69% | 1,545.00% | -76.26% | 191.57% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 2,644.53% | 203.69% | -212.39% | 137.34% | -44.99% |
| Foreign Exchange rate Adjustments | -57.81% | 574.63% | 106.96% | -276.35% | 580.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 418.39% | 336.23% | 30.51% | -262.98% | 150.39% |